parmar-ceuticals limited Company Information
Company Number
03496193
Next Accounts
Aug 2025
Industry
Dispensing chemist in specialised stores
Shareholders
mr jai nagin parmar
mr nagin bhagwanji parmar
Group Structure
View All
Contact
Registered Address
1 tudor gardens, kingsbury, london, NW9 8RL
parmar-ceuticals limited Estimated Valuation
Pomanda estimates the enterprise value of PARMAR-CEUTICALS LIMITED at £725.3k based on a Turnover of £2.4m and 0.3x industry multiple (adjusted for size and gross margin).
parmar-ceuticals limited Estimated Valuation
Pomanda estimates the enterprise value of PARMAR-CEUTICALS LIMITED at £374.7k based on an EBITDA of £107.2k and a 3.5x industry multiple (adjusted for size and gross margin).
parmar-ceuticals limited Estimated Valuation
Pomanda estimates the enterprise value of PARMAR-CEUTICALS LIMITED at £1.6m based on Net Assets of £733.2k and 2.13x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Parmar-ceuticals Limited Overview
Parmar-ceuticals Limited is a live company located in london, NW9 8RL with a Companies House number of 03496193. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in January 1998, it's largest shareholder is mr jai nagin parmar with a 50% stake. Parmar-ceuticals Limited is a mature, small sized company, Pomanda has estimated its turnover at £2.4m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Parmar-ceuticals Limited Health Check
Pomanda's financial health check has awarded Parmar-Ceuticals Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs
5 Strong
3 Regular
4 Weak
Size
annual sales of £2.4m, make it smaller than the average company (£12.6m)
- Parmar-ceuticals Limited
£12.6m - Industry AVG
Growth
3 year (CAGR) sales growth of 35%, show it is growing at a faster rate (7.6%)
- Parmar-ceuticals Limited
7.6% - Industry AVG
Production
with a gross margin of 27%, this company has a comparable cost of product (32.4%)
- Parmar-ceuticals Limited
32.4% - Industry AVG
Profitability
an operating margin of 4.3% make it more profitable than the average company (2.9%)
- Parmar-ceuticals Limited
2.9% - Industry AVG
Employees
with 11 employees, this is below the industry average (75)
11 - Parmar-ceuticals Limited
75 - Industry AVG
Pay Structure
on an average salary of £26.5k, the company has an equivalent pay structure (£26.5k)
- Parmar-ceuticals Limited
£26.5k - Industry AVG
Efficiency
resulting in sales per employee of £220.8k, this is more efficient (£143.9k)
- Parmar-ceuticals Limited
£143.9k - Industry AVG
Debtor Days
it gets paid by customers after 94 days, this is later than average (30 days)
- Parmar-ceuticals Limited
30 days - Industry AVG
Creditor Days
its suppliers are paid after 33 days, this is quicker than average (64 days)
- Parmar-ceuticals Limited
64 days - Industry AVG
Stock Days
it holds stock equivalent to 39 days, this is in line with average (34 days)
- Parmar-ceuticals Limited
34 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 34 weeks, this is more cash available to meet short term requirements (14 weeks)
34 weeks - Parmar-ceuticals Limited
14 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 25.2%, this is a lower level of debt than the average (59.4%)
25.2% - Parmar-ceuticals Limited
59.4% - Industry AVG
PARMAR-CEUTICALS LIMITED financials
Parmar-Ceuticals Limited's latest turnover from November 2023 is estimated at £2.4 million and the company has net assets of £733.2 thousand. According to their latest financial statements, Parmar-Ceuticals Limited has 11 employees and maintains cash reserves of £110.6 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Oct 2019 | Oct 2018 | Oct 2017 | Oct 2016 | Oct 2015 | Oct 2014 | Oct 2013 | Oct 2012 | Oct 2011 | Oct 2010 | Oct 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | |||||||||||||||
Interest Payable | |||||||||||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | |||||||||||||||
Tax | |||||||||||||||
Profit After Tax | |||||||||||||||
Dividends Paid | |||||||||||||||
Retained Profit | |||||||||||||||
Employee Costs | |||||||||||||||
Number Of Employees | 11 | 11 | 11 | 11 | 11 | 12 | 11 | 11 | |||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Oct 2019 | Oct 2018 | Oct 2017 | Oct 2016 | Oct 2015 | Oct 2014 | Oct 2013 | Oct 2012 | Oct 2011 | Oct 2010 | Oct 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 13,277 | 11,853 | 11,570 | 11,306 | 13,689 | 13,609 | 15,547 | 18,657 | 22,433 | 27,042 | 21,118 | 25,771 | 31,198 | 38,997 | 43,745 |
Intangible Assets | 2 | 2 | 2 | 11,303 | 22,604 | 33,905 | 45,206 | 56,507 | 67,808 | 79,109 | 90,410 | 101,711 | 113,012 | 124,313 | 135,614 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 13,279 | 11,855 | 11,572 | 22,609 | 36,293 | 47,514 | 60,753 | 75,164 | 90,241 | 106,151 | 111,528 | 127,482 | 144,210 | 163,310 | 179,359 |
Stock & work in progress | 194,285 | 178,190 | 175,728 | 202,123 | 195,258 | 205,853 | 177,484 | 175,684 | 156,547 | 145,848 | 137,242 | 150,923 | 170,101 | 156,927 | 167,461 |
Trade Debtors | 626,389 | 243,282 | 199,504 | 178,595 | 151,614 | 143,913 | 131,835 | 131,044 | 96,315 | 86,380 | 110,385 | 116,144 | 121,965 | 132,345 | 0 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 83,632 |
Cash | 110,624 | 341,377 | 390,423 | 245,634 | 183,237 | 166,818 | 160,719 | 160,933 | 141,944 | 105,480 | 167,371 | 82,861 | 76,959 | 48,838 | 59,885 |
misc current assets | 35,000 | 35,000 | 20,000 | 20,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 966,298 | 797,849 | 785,655 | 646,352 | 530,109 | 516,584 | 470,038 | 467,661 | 394,806 | 337,708 | 414,998 | 349,928 | 369,025 | 338,110 | 310,978 |
total assets | 979,577 | 809,704 | 797,227 | 668,961 | 566,402 | 564,098 | 530,791 | 542,825 | 485,047 | 443,859 | 526,526 | 477,410 | 513,235 | 501,420 | 490,337 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 164,394 | 119,661 | 202,905 | 184,777 | 120,535 | 182,257 | 139,751 | 161,656 | 158,849 | 116,482 | 147,164 | 136,032 | 158,839 | 199,526 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 179,092 |
total current liabilities | 164,394 | 119,661 | 202,905 | 184,777 | 120,535 | 182,257 | 139,751 | 161,656 | 158,849 | 116,482 | 147,164 | 136,032 | 158,839 | 199,526 | 179,092 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 61,893 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 82,025 | 43,779 | 74,125 | 58,249 | 73,747 | 78,986 | 84,499 | 77,281 | 86,770 | 71,857 | 89,789 | 13,494 | 16,255 | 4,592 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 82,025 | 43,779 | 74,125 | 58,249 | 73,747 | 78,986 | 84,499 | 77,281 | 86,770 | 71,857 | 89,789 | 13,494 | 16,255 | 4,592 | 61,893 |
total liabilities | 246,419 | 163,440 | 277,030 | 243,026 | 194,282 | 261,243 | 224,250 | 238,937 | 245,619 | 188,339 | 236,953 | 149,526 | 175,094 | 204,118 | 240,985 |
net assets | 733,158 | 646,264 | 520,197 | 425,935 | 372,120 | 302,855 | 306,541 | 303,888 | 239,428 | 255,520 | 289,573 | 327,884 | 338,141 | 297,302 | 249,352 |
total shareholders funds | 733,158 | 646,264 | 520,197 | 425,935 | 372,120 | 302,855 | 306,541 | 303,888 | 239,428 | 255,520 | 289,573 | 327,884 | 338,141 | 297,302 | 249,352 |
Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Oct 2019 | Oct 2018 | Oct 2017 | Oct 2016 | Oct 2015 | Oct 2014 | Oct 2013 | Oct 2012 | Oct 2011 | Oct 2010 | Oct 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | |||||||||||||||
Depreciation | 3,209 | 2,743 | 2,560 | 2,383 | 2,868 | 2,737 | 3,110 | 11,301 | 4,610 | 5,652 | 5,280 | 6,443 | 7,799 | 9,749 | 5,822 |
Amortisation | 0 | 0 | 11,301 | 11,301 | 11,301 | 11,301 | 11,301 | 3,777 | 11,301 | 11,301 | 11,301 | 11,301 | 0 | 11,301 | 11,301 |
Tax | |||||||||||||||
Stock | 16,095 | 2,462 | -26,395 | 6,865 | -10,595 | 28,369 | 1,800 | 19,137 | 10,699 | 8,606 | -13,681 | -19,178 | 13,174 | -10,534 | 167,461 |
Debtors | 383,107 | 43,778 | 20,909 | 26,981 | 7,701 | 12,078 | 791 | 34,729 | 9,935 | -24,005 | -5,759 | -5,821 | -10,380 | 48,713 | 83,632 |
Creditors | 44,733 | -83,244 | 18,128 | 64,242 | -61,722 | 42,506 | -21,905 | 2,807 | 42,367 | -30,682 | 11,132 | -22,807 | -40,687 | 199,526 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -179,092 | 179,092 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | |||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -61,893 | 61,893 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 38,246 | -30,346 | 15,876 | -15,498 | -5,239 | -5,513 | 7,218 | -9,489 | 14,913 | -17,932 | 76,295 | -2,761 | 11,663 | 4,592 | 0 |
share issue | |||||||||||||||
interest | |||||||||||||||
cash flow from financing | |||||||||||||||
cash and cash equivalents | |||||||||||||||
cash | -230,753 | -49,046 | 144,789 | 62,397 | 16,419 | 6,099 | -214 | 18,989 | 36,464 | -61,891 | 84,510 | 5,902 | 28,121 | -11,047 | 59,885 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -230,753 | -49,046 | 144,789 | 62,397 | 16,419 | 6,099 | -214 | 18,989 | 36,464 | -61,891 | 84,510 | 5,902 | 28,121 | -11,047 | 59,885 |
parmar-ceuticals limited Credit Report and Business Information
Parmar-ceuticals Limited Competitor Analysis
Perform a competitor analysis for parmar-ceuticals limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in NW9 area or any other competitors across 12 key performance metrics.
parmar-ceuticals limited Ownership
PARMAR-CEUTICALS LIMITED group structure
Parmar-Ceuticals Limited has no subsidiary companies.
Ultimate parent company
PARMAR-CEUTICALS LIMITED
03496193
parmar-ceuticals limited directors
Parmar-Ceuticals Limited currently has 2 directors. The longest serving directors include Mr Nagin Parmar (Jan 1998) and Mr Jai Parmar (Jan 1998).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Nagin Parmar | 82 years | Jan 1998 | - | Director | |
Mr Jai Parmar | 58 years | Jan 1998 | - | Director |
P&L
November 2023turnover
2.4m
+98%
operating profit
104k
0%
gross margin
27%
-5.82%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
November 2023net assets
733.2k
+0.13%
total assets
979.6k
+0.21%
cash
110.6k
-0.68%
net assets
Total assets minus all liabilities
parmar-ceuticals limited company details
company number
03496193
Type
Private limited with Share Capital
industry
47730 - Dispensing chemist in specialised stores
incorporation date
January 1998
age
26
incorporated
UK
ultimate parent company
accounts
Unaudited Abridged
last accounts submitted
November 2023
previous names
N/A
accountant
AUCTUS ACCOUNTANTS LTD
auditor
-
address
1 tudor gardens, kingsbury, london, NW9 8RL
Bank
-
Legal Advisor
-
parmar-ceuticals limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 4 charges/mortgages relating to parmar-ceuticals limited. Currently there are 1 open charges and 3 have been satisfied in the past.
parmar-ceuticals limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for PARMAR-CEUTICALS LIMITED. This can take several minutes, an email will notify you when this has completed.
parmar-ceuticals limited Companies House Filings - See Documents
date | description | view/download |
---|